Prohibits pharmacy benefits managers from operating pharmacy practice sites directly or indirectly.
Prohibits PBMs from owning or controlling pharmacy practice sites by July 1, 2027, to curb anticompetitive practices while allowing a limited special-permit process for rare drugs.